venBio Partners LLC
CIK
1776382
Location
SAN FRANCISCO, CA
Portfolio Value
Small
$519,380,252
Diversification
Moderately concentrated
Filing Date
Global Rank
#3,738
/ 8,794
▲ 912
· as of Jun 2026
Top Industry
Biotechnology
100.0%
Period ended 3 months ago
Filed Aug 14, 2026 · 50d
26 quarters · since Mar 2020
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
7 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
30.9%
−15.8 pts
Top 5
95.8%
−3.0 pts
Top 10
100.0%
0.0 pts
HHI
2,421
Moderately concentrated−1,141
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $519,380,252 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PHVS | Pharvaris N.V. | +4,126 | 4,643,430 | $160,569,809 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| HRMY | Harmony Biosciences Holdings, Inc. | −17,000 | 472,194 | $17,192,583 | |
| No positions match the current search. | |||||
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ARTV | Artiva Biotherapeutics, Inc. | 531,337 | $3,421,810 | |
| No positions match the current search. | ||||
7 tracked positions ·
$519,380,252 total
· filing declares
7 positions · $519,380,257
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 4,643,430 | $160,569,809 | 30.92% | |
| PBLS |
Parabilis Medicines, Inc.
Healthcare
|
NEW | 5,266,697 | $144,149,496 | 27.75% | |
| ALMS |
Alumis Inc.
Healthcare
|
Held | 4,528,408 | $127,429,401 | 24.53% | |
| ACHV |
Achieve Life Sciences, Inc.
Healthcare
|
NEW | 5,914,720 | $38,623,121 | 7.44% | |
| ALXO |
Alx Oncology Holdings Inc
Healthcare
|
Held | 12,884,638 | $26,671,200 | 5.14% | |
| HRMY |
Harmony Biosciences Holdings, Inc.
Healthcare
|
Reduced | 472,194 | $17,192,583 | 3.31% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
Held | 337,697 | $4,744,642 | 0.91% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.